 |
PDBsum entry 6a3c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transport protein
|
PDB id
|
|
|
|
6a3c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
210 a.a.
|
|
|
|
|
|
|
|
|
|
|
128 a.a.
|
|
|
|
|
|
|
|
|
|
|
996 a.a.
|
|
|
|
|
|
|
|
|
|
|
18 a.a.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
Cancer therapy with nanoparticle-Medicated intracellular expression of peptide crm1-Inhibitor.
|
|
|
Authors
|
|
M.Sui,
M.Xiong,
Y.Li,
Q.Zhou,
X.Shen,
D.Jia,
M.Gou,
Q.Sun.
|
|
|
Ref.
|
|
Int J Nanomedicine, 2021,
16,
2833-2847.
[DOI no: ]
|
|
|
PubMed id
|
|
|
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
|
|
|
|
